Evaluation of Relapse, Efficacy and Safety of Long-term Treatment With Oracea® vs Placebo

Summary

The purpose of this study is to assess relapse, efficacy and safety in subjects with rosacea during long-term treatment with either Oracea® or placebo, after an initial 12-week regimen of Oracea® and MetroGel® 1%.

Timeline

Start

2011-09

Primary completion

2013-06

Completion

2013-06

Drugs

Indications